Lose Up to 22.5% Body Weight With Clinically Proven Injections

Weight loss injections are typically suitable for adults with a BMI of 30 or above (obese), or a BMI of 27 or above (overweight) with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol. Our pharmacist will assess your eligibility during your consultation.

Clinical trials have shown that patients using Wegovy (semaglutide) can lose up to 20.7% of their body weight, while Mounjaro (tirzepatide) has demonstrated weight loss of up to 22.5%. Individual results will vary based on your starting weight, adherence to the programme, and lifestyle factors.

Yes. Both Wegovy and Mounjaro are fully approved by the MHRA (UK) and FDA (US) after extensive clinical trials involving thousands of patients. Before prescribing, our pharmacist conducts a thorough health assessment to ensure the treatment is safe and appropriate for you.

The eligibility check is free. Weight loss medication starts from £32 per week (£139.99/month), depending on the treatment and dosage prescribed. A clinician reviews your assessment at no extra charge before approving your prescription.

Yes. We offer virtual consultations online as well as in-clinic appointments. Virtual appointments are available wherever you are in the UK.

Yes. We offer free tracked delivery across the UK for all weight loss medications.